title: Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab.
authors.forename: Beata
authors.initials: B
authors.lastname: Nowak
authors.forename: Sławomir
authors.initials: S
authors.lastname: Jeka
authors.forename: Piotr
authors.initials: P
authors.lastname: Wiland
authors.forename: Jacek
authors.initials: J
authors.lastname: Szechiński
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000686:Amyloidosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D001201:Ascites / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D006876:Hydrothorax / Q000188:drug therapy / Q000473:pathology; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab